Colorectal cancer is common with an annual prevalence of 6000. The majority can be cured and the five year survival rate is over 60%. In december 2019 reports came in about SARS-Cov-2, which later was named Covid-19. The World Health Organization classified it as a pandemic in March 2020. In Sweden the number of patients with Covid-19 increased mainly in the urban areas in March 2020. Care for patients with other diseases were affected and local changes from guidelines were adopted. In some regions and countries the indications for adjuvant and neoadjuvant treatment for colorectal cancer were somewhat changed. The number of patients diagnosed with colorectal cancer also decreased, as well as other types of cancer. The true effect on outcome with a delayed diagnosis remains unknown. The aim of this study is to evaluate the effects of the Covid-19 pandemic on the diagnosis, treatment and survival of patients with colorectal cancer.
Study Type
OBSERVATIONAL
Enrollment
8,000
We will create a group of patients that are diagnosed before and after the pandemic and one group diagnosed during the pandemic
Dept. of Surgery, Sahlgrenska University Hospital/Ostra
Gothenburg, Sweden
RECRUITINGYearly incidence of rectal cancer
The number of patients diagnosed yearly 2019, 2020, 2021 and 2022
Time frame: 2019-2022
Symptoms at diagnosis
Symptoms at diagnosis as reported by patients
Time frame: 6 months prior diagnosis
Patient's delay
Delay from symptoms until doctors appointment
Time frame: 12 months prior diagnosis
Doctor's delay
Delay from doctor's appointment until diagnosis
Time frame: 12 months prior diagnosis
Treatment changes
Any changes from the treatment plan due to covid-19
Time frame: Diagnosis and 12 months following
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.